As the final day of the first quarter approaches, its fair to say its been three months of surprises.The mood at the end of 2022 was rather gloomy. Stocks took a beating as the Federal Reserve raced … [+11564 chars]
After Apple's third consecutive quarter of declining revenue, some Wall Street analysts say its valuation is looking stretched.
Sage Therapeutics says it is 'evaluating resource allocation, including pipeline prioritization and a workforce reorganization with a goal of extending our cash runway.'
The third in a flurry of recent tech IPOs, the software marketing firm priced its offering at the top of the expected range.